BAYER Supplement: Making Time for Change

Chairman’s introduction:
Macular degeneration and retinal disease, a major and growing worldwide health challenge
Prof Andrew Lotery, honorary consultant ophthalmologist, University Hospital Southampton and professor of ophthalmology, University of Southampton, chaired Bayer’s Satellite Symposium ‘Making time for change: using aflibercept solution for injection in a clinical setting’, Retina Day, the Royal College of Ophthalmologists Annual Congress, held 19
May 2014, Birmingham, UK.
“Age-related macular degeneration is the commonest cause of blindness in the western world,” explained Prof Lotery.1 “It affects up to 25 million people worldwide and up to 30,000 people are diagnosed with neovascular AMD each year in the United Kingdom alone.1,2 Studies evaluating age-specific prevalence of AMD show a strong rise with age,
and overall prevalence rates in the age groups 65-74 years and 75-84 years of 20 and 35 per cent, respectively.3 So there’s an escalating epidemic as the population ages and AMD is a major public health problem.”
Download Supplement - click here
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.